AU782659C - Herpes virus strains for gene therapy - Google Patents

Herpes virus strains for gene therapy

Info

Publication number
AU782659C
AU782659C AU26947/01A AU2694701A AU782659C AU 782659 C AU782659 C AU 782659C AU 26947/01 A AU26947/01 A AU 26947/01A AU 2694701 A AU2694701 A AU 2694701A AU 782659 C AU782659 C AU 782659C
Authority
AU
Australia
Prior art keywords
gene therapy
herpes virus
virus strains
strains
herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
AU26947/01A
Other versions
AU2694701A (en
AU782659B2 (en
Inventor
Robert Stuart Coffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovex Ltd
Original Assignee
Biovex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0001475A external-priority patent/GB0001475D0/en
Priority claimed from GB0002854A external-priority patent/GB0002854D0/en
Priority claimed from GB0100288A external-priority patent/GB0100288D0/en
Priority claimed from GB0100430A external-priority patent/GB0100430D0/en
Application filed by Biovex Ltd filed Critical Biovex Ltd
Priority claimed from PCT/GB2001/000225 external-priority patent/WO2001053505A2/en
Publication of AU2694701A publication Critical patent/AU2694701A/en
Application granted granted Critical
Publication of AU782659B2 publication Critical patent/AU782659B2/en
Publication of AU782659C publication Critical patent/AU782659C/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

AU26947/01A 2000-01-21 2001-01-22 Herpes virus strains for gene therapy Active 2026-01-22 AU782659C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0001475 2000-01-21
GB0001475A GB0001475D0 (en) 2000-01-21 2000-01-21 Virus strains
GB0002854 2000-02-08
GB0002854A GB0002854D0 (en) 2000-02-08 2000-02-08 Virus strains
GB0100288 2001-01-05
GB0100288A GB0100288D0 (en) 2001-01-05 2001-01-05 Virus strains
GB0100430 2001-01-06
GB0100430A GB0100430D0 (en) 2001-01-06 2001-01-06 Virus strains
PCT/GB2001/000225 WO2001053505A2 (en) 2000-01-21 2001-01-22 Herpes virus strains for gene therapy

Publications (3)

Publication Number Publication Date
AU2694701A AU2694701A (en) 2001-07-31
AU782659B2 AU782659B2 (en) 2005-08-18
AU782659C true AU782659C (en) 2012-04-26

Family

ID=

Similar Documents

Publication Publication Date Title
CY2016020I2 (en) HERPES VIRUS STRAIN FOR GENE THERAPY
AU2001244188A1 (en) Medicaments against viral diseases
AU2001245987A1 (en) Compositions and methods for gene therapy
AU1285300A (en) Hiv vaccine
AUPP967999A0 (en) Viral variants
AU2001260834A1 (en) The treatment of herpes
AU5223800A (en) Means for handling high-frequency energy
AU7737300A (en) Dna-cleaving rnase p rna
AU2001242625A1 (en) Gene sequence
AU2001264247A1 (en) GASC1 gene
GB0001476D0 (en) Herpes virus strains
AU6158700A (en) Vaccine
AU7318700A (en) Novel transaldolase gene
AU2002220416A1 (en) Oncolytic virus
ZA200205439B (en) Herpes virus strains.
AU3714800A (en) Hiv therapy
AU782659C (en) Herpes virus strains for gene therapy
AU4957800A (en) Vaccine against isa virus
AU5088600A (en) Gene therapy products
AU5811600A (en) Vaccine
AU2002224845A1 (en) Viral expression system
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
AU2001297753A1 (en) Yeast genes that affect viral replication
AU4552700A (en) Gene therapy